CVS Asks Drug Makers To Not Raise Net Prices Before 2020 Plan Bids

By John Wilkerson / March 22, 2019 at 5:12 PM
CVS Health this week is pressing drug makers to hold off raising net prices to help the insurer accurately set Medicare Part D bids for 2020, according to a CVS letter to 60 drug makers obtained by Inside Drug Pricing . Investor research firm Evercore ISI says the letter’s message seems aimed in part at Senate Finance Committee members who are about to hear publicly from pharmacy benefit manager executives about their role in rising drug prices. “[T]his ask positions...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.